VOAGE M 10/1000

About

VOAGE M 10/1000 is a combination oral antidiabetic medication containing dapagliflozin and metformin. Dapagliflozin, an SGLT2 inhibitor, works by increasing the excretion of glucose through the urine, thereby lowering blood glucose levels. Metformin, a biguanide, reduces glucose production by the liver, decreases glucose absorption from the gut, and improves the body's sensitivity to insulin. This dual action provides a comprehensive approach to managing hyperglycemia in type 2 diabetes.

This medication is prescribed for adults with type 2 diabetes mellitus to improve glycemic control when diet and exercise alone are insufficient. The combination of these two agents offers synergistic benefits, not only in reducing HbA1c but also in potentially contributing to weight loss and blood pressure reduction. Furthermore, dapagliflozin has demonstrated cardiovascular and renal protective effects, making VOAGE M a beneficial option for patients with co-existing cardiovascular or kidney conditions.

Uses

• Treatment of type 2 diabetes mellitus.
• As an adjunct to diet and exercise.
• To reduce the risk of cardiovascular death and heart failure hospitalization.
• To improve glycemic control in adults.

Directions For Use

Take VOAGE M 10/1000 orally, usually once or twice daily with meals, as directed by your healthcare provider. Do not crush or chew the tablets.

Benefits

• Effective reduction in HbA1c levels.
• Supports weight loss and blood pressure reduction.
• Provides cardiovascular and renal benefits.
• Dual mechanism of action for robust glucose control.
• Low risk of hypoglycemia when used alone.
• Convenience of a single tablet combination.

Side Effects

• Genital mycotic infections
• Urinary tract infections
• Increased urination
• Nausea
• Diarrhea
• Abdominal pain
• Dizziness
• Dehydration
• Hypotension
• Ketoacidosis (rare)
• Fournier's gangrene (rare)
• Lactic acidosis (rare, serious)

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of lactic acidosis (due to metformin) and dehydration, which can exacerbate SGLT2 inhibitor side effects.
• Pregnancy - Not recommended during the second and third trimesters of pregnancy. Consult your doctor for guidance.
• Breastfeeding - Avoid use while breastfeeding as it may pass into breast milk and harm the infant.
• Liver - Use with caution in patients with liver impairment. Metformin is contraindicated in severe hepatic dysfunction.
• Kidney - Dose adjustment or discontinuation is necessary based on eGFR. Not recommended for patients with severe renal impairment.
• Lung - Use with caution in patients with severe respiratory conditions that may predispose to hypoxia and increase the risk of lactic acidosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.